Authors:
Bewick, M
Conlon, M
Gerard, S
Lee, H
Parissenti, AM
Zhang, L
Gluck, S
Lafrenie, RM
Citation: M. Bewick et al., HER-2 expression is a prognostic factor in patients with metastatic breastcancer treated with a combination of high-dose cyclophosphamide, mitoxantrone, paclitaxel and autologous blood stem cell support, BONE MAR TR, 27(8), 2001, pp. 847-853